Lancet Oncology

New drug cuts risk of deadly transplant side effect in half

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive ...

Dec 02, 2013
popularity 5 / 5 (1) | comments 0

Researchers discover breakthrough in ovarian cancer

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...

Feb 14, 2013
popularity 5 / 5 (3) | comments 0 | with audio podcast

New drug shrinks brain tumours in melanoma patients

(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.

Oct 08, 2012
popularity not rated yet | comments 0 | with audio podcast

Study supports tobacco link to ovarian cancer

(Medical Xpress)—Researchers from Curtin University's School of Public Health have contributed to a comprehensive international study examining risk factors for ovarian cancer.

Sep 12, 2012
popularity not rated yet | comments 0 | with audio podcast